View Future GrowthUNID 過去の業績過去 基準チェック /16UNIDの収益は年間平均-23.5%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間0.3% 5.5%割合で 増加しています。 UNIDの自己資本利益率は5.9%であり、純利益率は4.8%です。主要情報-23.54%収益成長率-23.52%EPS成長率Chemicals 業界の成長13.95%収益成長率5.47%株主資本利益率5.86%ネット・マージン4.84%前回の決算情報31 Mar 2026最近の業績更新お知らせ • Apr 11UNID Company Ltd. to Report Q1, 2026 Results on Apr 22, 2026UNID Company Ltd. announced that they will report Q1, 2026 results on Apr 22, 2026Reported Earnings • Mar 14Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2025 results: EPS: ₩9,830 (down from ₩11,483 in FY 2024). Revenue: ₩1.34t (up 20% from FY 2024). Net income: ₩65.3b (down 14% from FY 2024). Profit margin: 4.9% (down from 6.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 10%. Revenue is forecast to grow 9.8% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.お知らせ • Jan 12UNID Company Ltd. to Report Q4, 2025 Results on Jan 26, 2026UNID Company Ltd. announced that they will report Q4, 2025 results on Jan 26, 2026Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩2,535 (vs ₩2,988 in 3Q 2024)Third quarter 2025 results: EPS: ₩2,535 (down from ₩2,988 in 3Q 2024). Revenue: ₩329.0b (up 14% from 3Q 2024). Net income: ₩16.8b (down 15% from 3Q 2024). Profit margin: 5.1% (down from 6.8% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.お知らせ • Oct 14UNID Company Ltd. to Report Q3, 2025 Results on Oct 27, 2025UNID Company Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025分析記事 • Aug 20Investors Shouldn't Be Too Comfortable With UNID's (KRX:014830) EarningsUNID Company Ltd.'s ( KRX:014830 ) robust earnings report didn't manage to move the market for its stock. Our analysis...すべての更新を表示Recent updatesお知らせ • Apr 11UNID Company Ltd. to Report Q1, 2026 Results on Apr 22, 2026UNID Company Ltd. announced that they will report Q1, 2026 results on Apr 22, 2026Reported Earnings • Mar 14Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2025 results: EPS: ₩9,830 (down from ₩11,483 in FY 2024). Revenue: ₩1.34t (up 20% from FY 2024). Net income: ₩65.3b (down 14% from FY 2024). Profit margin: 4.9% (down from 6.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 10%. Revenue is forecast to grow 9.8% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.お知らせ • Feb 04+ 1 more updateUNID Company Ltd. announces Annual dividendUNID Company Ltd. announced Annual dividend of KRW 2000.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.お知らせ • Jan 12UNID Company Ltd. to Report Q4, 2025 Results on Jan 26, 2026UNID Company Ltd. announced that they will report Q4, 2025 results on Jan 26, 2026Price Target Changed • Dec 03Price target decreased by 8.5% to ₩100,333Down from ₩109,667, the current price target is an average from 6 analysts. New target price is 52% above last closing price of ₩65,900. Stock is up 5.1% over the past year. The company is forecast to post earnings per share of ₩10,899 for next year compared to ₩11,483 last year.Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩2,535 (vs ₩2,988 in 3Q 2024)Third quarter 2025 results: EPS: ₩2,535 (down from ₩2,988 in 3Q 2024). Revenue: ₩329.0b (up 14% from 3Q 2024). Net income: ₩16.8b (down 15% from 3Q 2024). Profit margin: 5.1% (down from 6.8% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.お知らせ • Oct 14UNID Company Ltd. to Report Q3, 2025 Results on Oct 27, 2025UNID Company Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025Major Estimate Revision • Oct 01Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩13,833 to ₩12,333 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 24% next year vs 48% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩116,600 to ₩112,600. Share price fell 4.5% to ₩70,600 over the past week.分析記事 • Aug 20Investors Shouldn't Be Too Comfortable With UNID's (KRX:014830) EarningsUNID Company Ltd.'s ( KRX:014830 ) robust earnings report didn't manage to move the market for its stock. Our analysis...Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: ₩3,581 (vs ₩4,089 in 2Q 2024)Second quarter 2025 results: EPS: ₩3,581 (down from ₩4,089 in 2Q 2024). Revenue: ₩340.9b (up 17% from 2Q 2024). Net income: ₩23.8b (down 12% from 2Q 2024). Profit margin: 7.0% (down from 9.3% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 15% per year.お知らせ • Jul 09UNID Company Ltd. to Report Q2, 2025 Results on Jul 23, 2025UNID Company Ltd. announced that they will report Q2, 2025 results on Jul 23, 2025分析記事 • May 07UNID Company Ltd.'s (KRX:014830) Share Price Boosted 25% But Its Business Prospects Need A Lift TooThe UNID Company Ltd. ( KRX:014830 ) share price has done very well over the last month, posting an excellent gain of...分析記事 • Apr 15Investors Met With Slowing Returns on Capital At UNID (KRX:014830)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩81,600, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past three years.お知らせ • Apr 09UNID Company Ltd. to Report Q1, 2025 Results on Apr 23, 2025UNID Company Ltd. announced that they will report Q1, 2025 results at 12:00 PM, Korea Standard Time on Apr 23, 2025Major Estimate Revision • Apr 03Consensus EPS estimates increase by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from ₩1.31b to ₩1.35b. EPS estimate increased from ₩12,717 to ₩14,011 per share. Net income forecast to grow 24% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩108,800 unchanged from last update. Share price fell 2.8% to ₩74,200 over the past week.Major Estimate Revision • Mar 21Consensus EPS estimates fall by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩1.41b to ₩1.31b. EPS estimate also fell from ₩14,305 per share to ₩12,717 per share. Net income forecast to grow 13% next year vs 28% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩108,800 unchanged from last update. Share price was steady at ₩77,400 over the past week.Reported Earnings • Mar 14Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: ₩11,483 (up from ₩2,454 in FY 2023). Revenue: ₩1.11t (down 1.9% from FY 2023). Net income: ₩76.2b (up 369% from FY 2023). Profit margin: 6.9% (up from 1.4% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 2.6%. Revenue is forecast to grow 7.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.分析記事 • Mar 04UNID Company Ltd.'s (KRX:014830) Shares Leap 30% Yet They're Still Not Telling The Full StoryUNID Company Ltd. ( KRX:014830 ) shareholders have had their patience rewarded with a 30% share price jump in the last...分析記事 • Feb 18Here's Why UNID (KRX:014830) Can Manage Its Debt ResponsiblyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...お知らせ • Feb 06UNID Company Ltd., Annual General Meeting, Mar 20, 2025UNID Company Ltd., Annual General Meeting, Mar 20, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 19, eulji-ro 5-gil, jung-gu, seoul South KoreaPrice Target Changed • Jan 22Price target decreased by 9.0% to ₩113,167Down from ₩124,400, the current price target is an average from 6 analysts. New target price is 67% above last closing price of ₩67,700. Stock is down 0.7% over the past year. The company is forecast to post earnings per share of ₩11,719 for next year compared to ₩2,450 last year.お知らせ • Jan 15UNID Company Ltd. to Report Q4, 2024 Final Results on Jan 31, 2025UNID Company Ltd. announced that they will report Q4, 2024 final results at 12:00 PM, Korea Standard Time on Jan 31, 2025分析記事 • Jan 08What UNID Company Ltd.'s (KRX:014830) 26% Share Price Gain Is Not Telling YouUNID Company Ltd. ( KRX:014830 ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩72,700, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total loss to shareholders of 39% over the past three years.分析記事 • Dec 16Returns On Capital At UNID (KRX:014830) Have StalledTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...Reported Earnings • Nov 15Third quarter 2024 earnings released: EPS: ₩2,988 (vs ₩274 loss in 3Q 2023)Third quarter 2024 results: EPS: ₩2,988 (up from ₩274 loss in 3Q 2023). Revenue: ₩289.8b (up 16% from 3Q 2023). Net income: ₩19.8b (up ₩21.7b from 3Q 2023). Profit margin: 6.8% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.分析記事 • Nov 13Cautious Investors Not Rewarding UNID Company Ltd.'s (KRX:014830) Performance CompletelyWith a price-to-earnings (or "P/E") ratio of 6.7x UNID Company Ltd. ( KRX:014830 ) may be sending bullish signals at...Price Target Changed • Oct 23Price target decreased by 8.6% to ₩117,400Down from ₩128,400, the current price target is an average from 5 analysts. New target price is 74% above last closing price of ₩67,500. Stock is down 2.0% over the past year. The company is forecast to post earnings per share of ₩12,548 for next year compared to ₩2,450 last year.分析記事 • Sep 27Is UNID (KRX:014830) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Buy Or Sell Opportunity • Aug 02Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to ₩83,900. The fair value is estimated to be ₩108,313, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 185% in the next 2 years.分析記事 • Jul 30A Look At The Fair Value Of UNID Company Ltd. (KRX:014830)Key Insights Using the 2 Stage Free Cash Flow to Equity, UNID fair value estimate is ₩97,397 Current share price of...お知らせ • Jul 17UNID Company Ltd. to Report Q2, 2024 Results on Jul 24, 2024UNID Company Ltd. announced that they will report Q2, 2024 results on Jul 24, 2024Price Target Changed • Jun 08Price target increased by 14% to ₩118,750Up from ₩104,333, the current price target is an average from 4 analysts. New target price is 8.2% above last closing price of ₩109,700. Stock is up 66% over the past year. The company is forecast to post earnings per share of ₩13,794 for next year compared to ₩2,450 last year.Valuation Update With 7 Day Price Move • Apr 29Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩97,700, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 2.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩45,300 per share.Major Estimate Revision • Apr 26Consensus EPS estimates increase by 12%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from ₩10,888 to ₩12,173. Revenue forecast steady at ₩1.11b. Net income forecast to grow 407% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩104,333 to ₩107,667. Share price rose 14% to ₩93,200 over the past week.分析記事 • Apr 25Unpleasant Surprises Could Be In Store For UNID Company Ltd.'s (KRX:014830) SharesIt's not a stretch to say that UNID Company Ltd.'s ( KRX:014830 ) price-to-sales (or "P/S") ratio of 0.5x right now...Price Target Changed • Apr 18Price target increased by 7.9% to ₩104,333Up from ₩96,667, the current price target is an average from 3 analysts. New target price is 25% above last closing price of ₩83,200. Stock is up 18% over the past year. The company is forecast to post earnings per share of ₩10,888 for next year compared to ₩2,450 last year.お知らせ • Apr 17UNID Company Ltd. to Report Q1, 2024 Results on Apr 24, 2024UNID Company Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩82,300, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 1.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩38,930 per share.分析記事 • Mar 27Investors Can Find Comfort In UNID's (KRX:014830) Earnings QualityShareholders appeared unconcerned with UNID Company Ltd.'s ( KRX:014830 ) lackluster earnings report last week. We did...Reported Earnings • Mar 23Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: ₩2,450 (down from ₩14,220 in FY 2022). Revenue: ₩1.13t (down 19% from FY 2022). Net income: ₩16.3b (down 86% from FY 2022). Profit margin: 1.4% (down from 8.5% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 23%. Revenue is forecast to grow 1.5% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Dec 20Upcoming dividend of ₩2,000 per share at 2.9% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 08 April 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.9%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).Reported Earnings • Nov 17Third quarter 2023 earnings released: ₩274 loss per share (vs ₩3,496 profit in 3Q 2022)Third quarter 2023 results: ₩274 loss per share (down from ₩3,496 profit in 3Q 2022). Revenue: ₩250.7b (down 36% from 3Q 2022). Net loss: ₩1.82b (down 106% from profit in 3Q 2022). Revenue is expected to decline by 2.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South Korea are expected to grow by 16%. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩79,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 51% over the past three years.Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩70,800, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 32% over the past three years.Major Estimate Revision • Jul 26Consensus revenue estimates fall by 22%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩1.48b to ₩1.15b. EPS estimate fell from ₩15,938 to ₩3,887 per share. Net income forecast to shrink 55% next year vs 43% growth forecast for Chemicals industry in South Korea . Consensus price target down from ₩109,000 to ₩79,000. Share price fell 12% to ₩54,100 over the past week.お知らせ • Jul 24UNID Company Ltd. to Report Q2, 2023 Results on Jul 25, 2023UNID Company Ltd. announced that they will report Q2, 2023 results on Jul 25, 2023Reported Earnings • Mar 10Full year 2022 earnings released: EPS: ₩14,220 (vs ₩19,247 in FY 2021)Full year 2022 results: EPS: ₩14,220 (down from ₩19,247 in FY 2021). Revenue: ₩1.40t (up 60% from FY 2021). Net income: ₩119.2b (down 29% from FY 2021). Profit margin: 8.5% (down from 19% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 23% per year.Upcoming Dividend • Dec 21Upcoming dividend of ₩1,700 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Payout ratio is a comfortable 10% but the company is not cash flow positive. Trailing yield: 2.6%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.4%).Board Change • Nov 28Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩90,500, the stock trades at a trailing P/E ratio of 5.4x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 112% over the past three years.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩95,000, the stock trades at a trailing P/E ratio of 4.3x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 103% over the past three years.Reported Earnings • May 22First quarter 2022 earnings released: EPS: ₩5,352 (vs ₩4,254 in 1Q 2021)First quarter 2022 results: EPS: ₩5,352 (up from ₩4,254 in 1Q 2021). Revenue: ₩370.4b (up 43% from 1Q 2021). Net income: ₩46.7b (up 26% from 1Q 2021). Profit margin: 13% (down from 14% in 1Q 2021). Over the next year, revenue is forecast to grow 33%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Price Target Changed • Apr 27Price target decreased to ₩140,000Down from ₩160,000, the current price target is provided by 1 analyst. New target price is 7.7% above last closing price of ₩130,000. Stock is up 47% over the past year. The company posted earnings per share of ₩20,907 last year.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩113,500, the stock trades at a trailing P/E ratio of 5.4x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 150% over the past three years.Reported Earnings • Mar 12Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: ₩20,907 (up from ₩8,773 in FY 2020). Revenue: ₩1.10t (up 23% from FY 2020). Net income: ₩182.6b (up 137% from FY 2020). Profit margin: 17% (up from 8.6% in FY 2020). Revenue exceeded analyst estimates by 4.1%. Over the next year, revenue is forecast to grow 32%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩84,100, the stock trades at a trailing P/E ratio of 3.9x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 92% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩1,700 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 6.5% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).Reported Earnings • Nov 18Third quarter 2021 earnings released: EPS ₩4,184 (vs ₩2,635 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₩271.5b (up 27% from 3Q 2020). Net income: ₩36.5b (up 59% from 3Q 2020). Profit margin: 14% (up from 11% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩137,000, the stock trades at a trailing P/E ratio of 6.8x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 191% over the past three years.Valuation Update With 7 Day Price Move • Jul 23Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩108,500, the stock trades at a trailing P/E ratio of 9.7x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 139% over the past three years.Reported Earnings • May 20First quarter 2021 earnings released: EPS ₩4,254 (vs ₩1,882 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩259.6b (up 19% from 1Q 2020). Net income: ₩37.1b (up 122% from 1Q 2020). Profit margin: 14% (up from 7.7% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩79,900, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.分析記事 • Apr 06Here's Why I Think UNID (KRX:014830) Might Deserve Your Attention TodayIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...Is New 90 Day High Low • Mar 16New 90-day high: ₩68,300The company is up 47% from a price of ₩46,450 on 16 December 2020. Outperformed the South Korean market which is up 9.0% over the last 90 days. Exceeded the Chemicals industry, which is up 17% over the same period.Reported Earnings • Mar 13Full year 2020 earnings released: EPS ₩8,773 (vs ₩7,600 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩890.5b (up 1.7% from FY 2019). Net income: ₩76.9b (up 14% from FY 2019). Profit margin: 8.6% (up from 7.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.分析記事 • Mar 08We Think UNID (KRX:014830) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...分析記事 • Feb 18Will The ROCE Trend At UNID (KRX:014830) Continue?To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...お知らせ • Feb 18UNID Company Ltd., Annual General Meeting, Mar 18, 2021UNID Company Ltd., Annual General Meeting, Mar 18, 2021, at 10:00 Korea Standard Time.Is New 90 Day High Low • Feb 05New 90-day high: ₩56,300The company is up 27% from its price of ₩44,400 on 06 November 2020. The South Korean market is up 26% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 29% over the same period.分析記事 • Jan 31Is UNID Company Ltd. (KRX:014830) An Attractive Dividend Stock?Today we'll take a closer look at UNID Company Ltd. ( KRX:014830 ) from a dividend investor's perspective. Owning a...Is New 90 Day High Low • Jan 21New 90-day high: ₩51,400The company is up 13% from its price of ₩45,300 on 23 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period.分析記事 • Jan 13Can You Imagine How UNID's (KRX:014830) Shareholders Feel About The 11% Share Price Increase?When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...Is New 90 Day High Low • Jan 05New 90-day high: ₩49,650The company is up 9.0% from its price of ₩45,750 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period.分析記事 • Dec 24UNID Company Ltd. (KRX:014830) Looks Like A Good Stock, And It's Going Ex-Dividend SoonSome investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...Is New 90 Day High Low • Dec 18New 90-day high: ₩48,800The company is up 3.0% from its price of ₩47,450 on 18 September 2020. The South Korean market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.分析記事 • Dec 17Is UNID Company Ltd. (KRX:014830) Popular Amongst Insiders?Every investor in UNID Company Ltd. ( KRX:014830 ) should be aware of the most powerful shareholder groups...Is New 90 Day High Low • Oct 30New 90-day low: ₩43,200The company is down 10.0% from its price of ₩48,000 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.収支内訳UNID の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSE:A014830 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Mar 261,400,66467,826122,48021,46331 Dec 251,338,75865,259119,77520,53030 Sep 251,267,93270,502115,80119,14530 Jun 251,228,73773,508115,22118,95431 Mar 251,179,43576,877113,54616,79931 Dec 241,111,63176,235113,88116,73730 Sep 241,083,45082,096109,01916,38930 Jun 241,044,37460,445106,52615,78531 Mar 241,053,88537,693102,71816,18331 Dec 231,133,71516,265100,03416,23330 Sep 231,232,868-1,535108,28716,84330 Jun 231,375,32630,806109,39118,52331 Mar 231,432,40178,264110,73019,63731 Dec 221,404,902119,191110,37820,06630 Sep 221,133,069115,26386,34919,79130 Jun 221,011,409121,27085,40817,79431 Mar 22924,520172,07281,55716,08431 Dec 21877,110168,06179,54215,09230 Sep 211,028,217188,50893,79615,00530 Jun 21971,147174,97889,62715,16631 Mar 21932,04097,36887,78914,95631 Dec 20890,46076,94785,39814,91630 Sep 20877,35070,23683,30418,53130 Jun 20888,57178,39882,98718,91931 Mar 20881,69368,22886,26715,86431 Dec 19875,16467,56386,31613,55530 Sep 19876,19169,36084,9646,54530 Jun 19855,26951,66686,0952,75131 Mar 19836,53643,57083,3492,92031 Dec 18814,00836,11282,6882,93430 Sep 18792,23033,82190,2893,48530 Jun 18779,11228,19495,9513,91131 Mar 18766,24036,552101,8204,44231 Dec 17762,38739,591106,4725,16230 Sep 17752,56459,122103,0434,41930 Jun 17727,03960,559100,4205,98931 Mar 17738,21157,26697,3686,56331 Dec 16740,88449,86296,8856,34630 Sep 16742,76817,035100,6547,21130 Jun 16764,69610,73798,5215,58731 Mar 16729,60371,15196,6474,94431 Dec 15708,21875,88595,1194,86630 Sep 15687,22988,44291,9285,74230 Jun 15666,58897,60591,4216,039質の高い収益: A014830は 高品質の収益 を持っています。利益率の向上: A014830の現在の純利益率 (4.8%)は、昨年(6.5%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A014830の収益は過去 5 年間で年間23.5%減少しました。成長の加速: A014830は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: A014830は過去 1 年間で収益成長率がマイナス ( -11.8% ) となったため、 Chemicals業界平均 ( -3.3% ) と比較することが困難です。株主資本利益率高いROE: A014830の 自己資本利益率 ( 5.9% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/31 21:02終値2026/05/29 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋UNID Company Ltd. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Jungwon WeeDaishin Securities Co. Ltd.Jinhee KwakEugene Investment & Securities Co Ltd.Dong Jin KangHyundai Motor Securities Co. Ltd.5 その他のアナリストを表示
お知らせ • Apr 11UNID Company Ltd. to Report Q1, 2026 Results on Apr 22, 2026UNID Company Ltd. announced that they will report Q1, 2026 results on Apr 22, 2026
Reported Earnings • Mar 14Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2025 results: EPS: ₩9,830 (down from ₩11,483 in FY 2024). Revenue: ₩1.34t (up 20% from FY 2024). Net income: ₩65.3b (down 14% from FY 2024). Profit margin: 4.9% (down from 6.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 10%. Revenue is forecast to grow 9.8% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.
お知らせ • Jan 12UNID Company Ltd. to Report Q4, 2025 Results on Jan 26, 2026UNID Company Ltd. announced that they will report Q4, 2025 results on Jan 26, 2026
Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩2,535 (vs ₩2,988 in 3Q 2024)Third quarter 2025 results: EPS: ₩2,535 (down from ₩2,988 in 3Q 2024). Revenue: ₩329.0b (up 14% from 3Q 2024). Net income: ₩16.8b (down 15% from 3Q 2024). Profit margin: 5.1% (down from 6.8% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.
お知らせ • Oct 14UNID Company Ltd. to Report Q3, 2025 Results on Oct 27, 2025UNID Company Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025
分析記事 • Aug 20Investors Shouldn't Be Too Comfortable With UNID's (KRX:014830) EarningsUNID Company Ltd.'s ( KRX:014830 ) robust earnings report didn't manage to move the market for its stock. Our analysis...
お知らせ • Apr 11UNID Company Ltd. to Report Q1, 2026 Results on Apr 22, 2026UNID Company Ltd. announced that they will report Q1, 2026 results on Apr 22, 2026
Reported Earnings • Mar 14Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2025 results: EPS: ₩9,830 (down from ₩11,483 in FY 2024). Revenue: ₩1.34t (up 20% from FY 2024). Net income: ₩65.3b (down 14% from FY 2024). Profit margin: 4.9% (down from 6.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 10%. Revenue is forecast to grow 9.8% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.
お知らせ • Feb 04+ 1 more updateUNID Company Ltd. announces Annual dividendUNID Company Ltd. announced Annual dividend of KRW 2000.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.
お知らせ • Jan 12UNID Company Ltd. to Report Q4, 2025 Results on Jan 26, 2026UNID Company Ltd. announced that they will report Q4, 2025 results on Jan 26, 2026
Price Target Changed • Dec 03Price target decreased by 8.5% to ₩100,333Down from ₩109,667, the current price target is an average from 6 analysts. New target price is 52% above last closing price of ₩65,900. Stock is up 5.1% over the past year. The company is forecast to post earnings per share of ₩10,899 for next year compared to ₩11,483 last year.
Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩2,535 (vs ₩2,988 in 3Q 2024)Third quarter 2025 results: EPS: ₩2,535 (down from ₩2,988 in 3Q 2024). Revenue: ₩329.0b (up 14% from 3Q 2024). Net income: ₩16.8b (down 15% from 3Q 2024). Profit margin: 5.1% (down from 6.8% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.
お知らせ • Oct 14UNID Company Ltd. to Report Q3, 2025 Results on Oct 27, 2025UNID Company Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025
Major Estimate Revision • Oct 01Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩13,833 to ₩12,333 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 24% next year vs 48% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩116,600 to ₩112,600. Share price fell 4.5% to ₩70,600 over the past week.
分析記事 • Aug 20Investors Shouldn't Be Too Comfortable With UNID's (KRX:014830) EarningsUNID Company Ltd.'s ( KRX:014830 ) robust earnings report didn't manage to move the market for its stock. Our analysis...
Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: ₩3,581 (vs ₩4,089 in 2Q 2024)Second quarter 2025 results: EPS: ₩3,581 (down from ₩4,089 in 2Q 2024). Revenue: ₩340.9b (up 17% from 2Q 2024). Net income: ₩23.8b (down 12% from 2Q 2024). Profit margin: 7.0% (down from 9.3% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 15% per year.
お知らせ • Jul 09UNID Company Ltd. to Report Q2, 2025 Results on Jul 23, 2025UNID Company Ltd. announced that they will report Q2, 2025 results on Jul 23, 2025
分析記事 • May 07UNID Company Ltd.'s (KRX:014830) Share Price Boosted 25% But Its Business Prospects Need A Lift TooThe UNID Company Ltd. ( KRX:014830 ) share price has done very well over the last month, posting an excellent gain of...
分析記事 • Apr 15Investors Met With Slowing Returns on Capital At UNID (KRX:014830)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩81,600, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past three years.
お知らせ • Apr 09UNID Company Ltd. to Report Q1, 2025 Results on Apr 23, 2025UNID Company Ltd. announced that they will report Q1, 2025 results at 12:00 PM, Korea Standard Time on Apr 23, 2025
Major Estimate Revision • Apr 03Consensus EPS estimates increase by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from ₩1.31b to ₩1.35b. EPS estimate increased from ₩12,717 to ₩14,011 per share. Net income forecast to grow 24% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩108,800 unchanged from last update. Share price fell 2.8% to ₩74,200 over the past week.
Major Estimate Revision • Mar 21Consensus EPS estimates fall by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩1.41b to ₩1.31b. EPS estimate also fell from ₩14,305 per share to ₩12,717 per share. Net income forecast to grow 13% next year vs 28% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩108,800 unchanged from last update. Share price was steady at ₩77,400 over the past week.
Reported Earnings • Mar 14Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: ₩11,483 (up from ₩2,454 in FY 2023). Revenue: ₩1.11t (down 1.9% from FY 2023). Net income: ₩76.2b (up 369% from FY 2023). Profit margin: 6.9% (up from 1.4% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 2.6%. Revenue is forecast to grow 7.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
分析記事 • Mar 04UNID Company Ltd.'s (KRX:014830) Shares Leap 30% Yet They're Still Not Telling The Full StoryUNID Company Ltd. ( KRX:014830 ) shareholders have had their patience rewarded with a 30% share price jump in the last...
分析記事 • Feb 18Here's Why UNID (KRX:014830) Can Manage Its Debt ResponsiblyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
お知らせ • Feb 06UNID Company Ltd., Annual General Meeting, Mar 20, 2025UNID Company Ltd., Annual General Meeting, Mar 20, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 19, eulji-ro 5-gil, jung-gu, seoul South Korea
Price Target Changed • Jan 22Price target decreased by 9.0% to ₩113,167Down from ₩124,400, the current price target is an average from 6 analysts. New target price is 67% above last closing price of ₩67,700. Stock is down 0.7% over the past year. The company is forecast to post earnings per share of ₩11,719 for next year compared to ₩2,450 last year.
お知らせ • Jan 15UNID Company Ltd. to Report Q4, 2024 Final Results on Jan 31, 2025UNID Company Ltd. announced that they will report Q4, 2024 final results at 12:00 PM, Korea Standard Time on Jan 31, 2025
分析記事 • Jan 08What UNID Company Ltd.'s (KRX:014830) 26% Share Price Gain Is Not Telling YouUNID Company Ltd. ( KRX:014830 ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...
Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩72,700, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total loss to shareholders of 39% over the past three years.
分析記事 • Dec 16Returns On Capital At UNID (KRX:014830) Have StalledTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
Reported Earnings • Nov 15Third quarter 2024 earnings released: EPS: ₩2,988 (vs ₩274 loss in 3Q 2023)Third quarter 2024 results: EPS: ₩2,988 (up from ₩274 loss in 3Q 2023). Revenue: ₩289.8b (up 16% from 3Q 2023). Net income: ₩19.8b (up ₩21.7b from 3Q 2023). Profit margin: 6.8% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
分析記事 • Nov 13Cautious Investors Not Rewarding UNID Company Ltd.'s (KRX:014830) Performance CompletelyWith a price-to-earnings (or "P/E") ratio of 6.7x UNID Company Ltd. ( KRX:014830 ) may be sending bullish signals at...
Price Target Changed • Oct 23Price target decreased by 8.6% to ₩117,400Down from ₩128,400, the current price target is an average from 5 analysts. New target price is 74% above last closing price of ₩67,500. Stock is down 2.0% over the past year. The company is forecast to post earnings per share of ₩12,548 for next year compared to ₩2,450 last year.
分析記事 • Sep 27Is UNID (KRX:014830) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Buy Or Sell Opportunity • Aug 02Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to ₩83,900. The fair value is estimated to be ₩108,313, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 185% in the next 2 years.
分析記事 • Jul 30A Look At The Fair Value Of UNID Company Ltd. (KRX:014830)Key Insights Using the 2 Stage Free Cash Flow to Equity, UNID fair value estimate is ₩97,397 Current share price of...
お知らせ • Jul 17UNID Company Ltd. to Report Q2, 2024 Results on Jul 24, 2024UNID Company Ltd. announced that they will report Q2, 2024 results on Jul 24, 2024
Price Target Changed • Jun 08Price target increased by 14% to ₩118,750Up from ₩104,333, the current price target is an average from 4 analysts. New target price is 8.2% above last closing price of ₩109,700. Stock is up 66% over the past year. The company is forecast to post earnings per share of ₩13,794 for next year compared to ₩2,450 last year.
Valuation Update With 7 Day Price Move • Apr 29Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩97,700, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 2.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩45,300 per share.
Major Estimate Revision • Apr 26Consensus EPS estimates increase by 12%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from ₩10,888 to ₩12,173. Revenue forecast steady at ₩1.11b. Net income forecast to grow 407% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩104,333 to ₩107,667. Share price rose 14% to ₩93,200 over the past week.
分析記事 • Apr 25Unpleasant Surprises Could Be In Store For UNID Company Ltd.'s (KRX:014830) SharesIt's not a stretch to say that UNID Company Ltd.'s ( KRX:014830 ) price-to-sales (or "P/S") ratio of 0.5x right now...
Price Target Changed • Apr 18Price target increased by 7.9% to ₩104,333Up from ₩96,667, the current price target is an average from 3 analysts. New target price is 25% above last closing price of ₩83,200. Stock is up 18% over the past year. The company is forecast to post earnings per share of ₩10,888 for next year compared to ₩2,450 last year.
お知らせ • Apr 17UNID Company Ltd. to Report Q1, 2024 Results on Apr 24, 2024UNID Company Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩82,300, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 1.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩38,930 per share.
分析記事 • Mar 27Investors Can Find Comfort In UNID's (KRX:014830) Earnings QualityShareholders appeared unconcerned with UNID Company Ltd.'s ( KRX:014830 ) lackluster earnings report last week. We did...
Reported Earnings • Mar 23Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: ₩2,450 (down from ₩14,220 in FY 2022). Revenue: ₩1.13t (down 19% from FY 2022). Net income: ₩16.3b (down 86% from FY 2022). Profit margin: 1.4% (down from 8.5% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 23%. Revenue is forecast to grow 1.5% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Dec 20Upcoming dividend of ₩2,000 per share at 2.9% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 08 April 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.9%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).
Reported Earnings • Nov 17Third quarter 2023 earnings released: ₩274 loss per share (vs ₩3,496 profit in 3Q 2022)Third quarter 2023 results: ₩274 loss per share (down from ₩3,496 profit in 3Q 2022). Revenue: ₩250.7b (down 36% from 3Q 2022). Net loss: ₩1.82b (down 106% from profit in 3Q 2022). Revenue is expected to decline by 2.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South Korea are expected to grow by 16%. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩79,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 51% over the past three years.
Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩70,800, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 32% over the past three years.
Major Estimate Revision • Jul 26Consensus revenue estimates fall by 22%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩1.48b to ₩1.15b. EPS estimate fell from ₩15,938 to ₩3,887 per share. Net income forecast to shrink 55% next year vs 43% growth forecast for Chemicals industry in South Korea . Consensus price target down from ₩109,000 to ₩79,000. Share price fell 12% to ₩54,100 over the past week.
お知らせ • Jul 24UNID Company Ltd. to Report Q2, 2023 Results on Jul 25, 2023UNID Company Ltd. announced that they will report Q2, 2023 results on Jul 25, 2023
Reported Earnings • Mar 10Full year 2022 earnings released: EPS: ₩14,220 (vs ₩19,247 in FY 2021)Full year 2022 results: EPS: ₩14,220 (down from ₩19,247 in FY 2021). Revenue: ₩1.40t (up 60% from FY 2021). Net income: ₩119.2b (down 29% from FY 2021). Profit margin: 8.5% (down from 19% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 23% per year.
Upcoming Dividend • Dec 21Upcoming dividend of ₩1,700 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Payout ratio is a comfortable 10% but the company is not cash flow positive. Trailing yield: 2.6%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.4%).
Board Change • Nov 28Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 26Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩90,500, the stock trades at a trailing P/E ratio of 5.4x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 112% over the past three years.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩95,000, the stock trades at a trailing P/E ratio of 4.3x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 103% over the past three years.
Reported Earnings • May 22First quarter 2022 earnings released: EPS: ₩5,352 (vs ₩4,254 in 1Q 2021)First quarter 2022 results: EPS: ₩5,352 (up from ₩4,254 in 1Q 2021). Revenue: ₩370.4b (up 43% from 1Q 2021). Net income: ₩46.7b (up 26% from 1Q 2021). Profit margin: 13% (down from 14% in 1Q 2021). Over the next year, revenue is forecast to grow 33%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Apr 27Price target decreased to ₩140,000Down from ₩160,000, the current price target is provided by 1 analyst. New target price is 7.7% above last closing price of ₩130,000. Stock is up 47% over the past year. The company posted earnings per share of ₩20,907 last year.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩113,500, the stock trades at a trailing P/E ratio of 5.4x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 150% over the past three years.
Reported Earnings • Mar 12Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: ₩20,907 (up from ₩8,773 in FY 2020). Revenue: ₩1.10t (up 23% from FY 2020). Net income: ₩182.6b (up 137% from FY 2020). Profit margin: 17% (up from 8.6% in FY 2020). Revenue exceeded analyst estimates by 4.1%. Over the next year, revenue is forecast to grow 32%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩84,100, the stock trades at a trailing P/E ratio of 3.9x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 92% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩1,700 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 6.5% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).
Reported Earnings • Nov 18Third quarter 2021 earnings released: EPS ₩4,184 (vs ₩2,635 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₩271.5b (up 27% from 3Q 2020). Net income: ₩36.5b (up 59% from 3Q 2020). Profit margin: 14% (up from 11% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩137,000, the stock trades at a trailing P/E ratio of 6.8x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 191% over the past three years.
Valuation Update With 7 Day Price Move • Jul 23Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩108,500, the stock trades at a trailing P/E ratio of 9.7x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 139% over the past three years.
Reported Earnings • May 20First quarter 2021 earnings released: EPS ₩4,254 (vs ₩1,882 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩259.6b (up 19% from 1Q 2020). Net income: ₩37.1b (up 122% from 1Q 2020). Profit margin: 14% (up from 7.7% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩79,900, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.
分析記事 • Apr 06Here's Why I Think UNID (KRX:014830) Might Deserve Your Attention TodayIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Is New 90 Day High Low • Mar 16New 90-day high: ₩68,300The company is up 47% from a price of ₩46,450 on 16 December 2020. Outperformed the South Korean market which is up 9.0% over the last 90 days. Exceeded the Chemicals industry, which is up 17% over the same period.
Reported Earnings • Mar 13Full year 2020 earnings released: EPS ₩8,773 (vs ₩7,600 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩890.5b (up 1.7% from FY 2019). Net income: ₩76.9b (up 14% from FY 2019). Profit margin: 8.6% (up from 7.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
分析記事 • Mar 08We Think UNID (KRX:014830) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
分析記事 • Feb 18Will The ROCE Trend At UNID (KRX:014830) Continue?To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
お知らせ • Feb 18UNID Company Ltd., Annual General Meeting, Mar 18, 2021UNID Company Ltd., Annual General Meeting, Mar 18, 2021, at 10:00 Korea Standard Time.
Is New 90 Day High Low • Feb 05New 90-day high: ₩56,300The company is up 27% from its price of ₩44,400 on 06 November 2020. The South Korean market is up 26% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 29% over the same period.
分析記事 • Jan 31Is UNID Company Ltd. (KRX:014830) An Attractive Dividend Stock?Today we'll take a closer look at UNID Company Ltd. ( KRX:014830 ) from a dividend investor's perspective. Owning a...
Is New 90 Day High Low • Jan 21New 90-day high: ₩51,400The company is up 13% from its price of ₩45,300 on 23 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period.
分析記事 • Jan 13Can You Imagine How UNID's (KRX:014830) Shareholders Feel About The 11% Share Price Increase?When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...
Is New 90 Day High Low • Jan 05New 90-day high: ₩49,650The company is up 9.0% from its price of ₩45,750 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period.
分析記事 • Dec 24UNID Company Ltd. (KRX:014830) Looks Like A Good Stock, And It's Going Ex-Dividend SoonSome investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Is New 90 Day High Low • Dec 18New 90-day high: ₩48,800The company is up 3.0% from its price of ₩47,450 on 18 September 2020. The South Korean market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.
分析記事 • Dec 17Is UNID Company Ltd. (KRX:014830) Popular Amongst Insiders?Every investor in UNID Company Ltd. ( KRX:014830 ) should be aware of the most powerful shareholder groups...
Is New 90 Day High Low • Oct 30New 90-day low: ₩43,200The company is down 10.0% from its price of ₩48,000 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.